HEL •
Healthcare •
Drug Manufacturers - General •
Quote as of 08/07/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeHEL
Market Capitalization11,262 mln
Float123 mln
Earnings Date10/28/2026
EPS
4.18
Solid
P / E
19.55
Moderately valued
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-1.41
Manipulation likely
1-Year Forecast
76.67
Limited downside
Relative Strength
69
/ 100
Outperforming
Business Description
Founded in Finland in 1917, Orion Oyj is a pharmaceutical company that creates and sells a wide range of medicines for both people and animals across Europe, North America, and beyond. Its human health portfolio covers treatments for conditions such as prostate cancer, Parkinson's disease, heart failure, asthma, and several other serious illnesses, while its animal health range serves veterinary needs worldwide. The company also produces active pharmaceutical ingredients, offers contract manufacturing, and sells self-care products including vitamins, supplements, and skincare items. Orion works alongside partners such as Bayer and Tenax Therapeutics to develop new treatments, and its products are available through both traditional and online channels.